Fundamental Analysis of Globus Medical - Growth / Value Index
GMED - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.070
Book Value in last 3 years is trending up
Tsr Value Index - Very Poor Score of 12.50
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 122.95 | 48.41 | 34.50 % | |
| Price to Book | 2.56 | 1.91 | -48.42 % | 2.50 |
| Price to Sales | 4.31 | 6.23 | -6.86 % | |
| Enterprise Value to EBITDA Multiple | 26.33 | 30.62 | 48.84 % |
GMED - Profitability Highlights
Profitability Analysis
Company Earning excess return
Piotroski F Score - Stable Value of 4.0
Tsr Profitability Index - Very Poor Score of 10.62
Very Low Dividend Yield of 0 %
EPS decline for last four quarters
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 2.08 | 3.95 | -61.65 % | -0.181 |
| Return On Asset | 1.69 | 3.10 | -66.11 % | -0.144 |
| Net Profit Margin | 3.51 | 12.87 | -30.75 % | -1.17 |
| Operating Profit Margin | 4.46 | 19.38 | -16.08 % | 1.32 |
| EBITDA Margin | 14.95 | 20.25 | -36.36 % | 1.32 |
Highlights
| Market Cap | 7509.97 M |
| Enterprise Value | 7472.04 M |
| Price/Book TTM | 2.56 |
| Outstanding Share | 112627 K |
| Float/ Outstanding Share | 99.14% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 3.23 |
| Peter Lynch Ratio | -0.209 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 5.12 |
| Sloan Ratio | -0.0088 |
| Peter Lynch Fair Value | 0 |
GMED - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 21.38
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1898.45 M | 19.91 % | 1.60 % |
| Gross Profit | 1179.62 M | 15.02 % | 4.03 % |
| EBITDA | 283825 K | 23.69 % | 91.40 % |
| Net Profit | 66627.00 K | 16.97 % | 147.34 % |
| EPS | 0.542 | 25.65 % | NA |
GMED - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 78.12
Altman Z Score of 5.09 suggests good Stability
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.107 | 7719.17 % | 0.0030 |
| Cash Ratio | 1.32 | -52.90 % | |
| Quick Ratio | 2.72 | -36.72 % | 1.29 |
| Shareholders Equity | 78.61 | -11.61 % | |
| Debt to EBITDA | 1.73 | 22087.60 % |
Historical Valuation Ratios of Globus Medical
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Globus Medical
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Globus Medical
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Globus Medical
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)